Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells. Raveendra-Panickar D, Finlay D, Layng FI, Lambert LJ, et al. J Biol Chem 2021 Dec 9:101477. doi: 10.1016/j.jbc.2021.101477.

Read + Share

Amedeo Smart

Independent Medical Education

Raveendra-Panickar D, Finlay D, Layng FI, Lambert LJ, et al. Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells. J Biol Chem 2021 Dec 9:101477. doi: 10.1016/j.jbc.2021.101477.
PMID: 34896393